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INTRODUCTION: Tissue engineering has the 
potential to serve as an alternative to surgical tissue 
transfer for the management of soft tissue defects. 
The perceived advantages include reduced donor 
site morbidity and restoration of function and 
aesthetics to ideal. Degradable scaffolds are 
utilised in the early stages of cell growth and 
development with the advantage of eventual 
elimination to leave space for the engineered tissue 
and a reduced chance of rejection. 
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METHODS: Cells were extracted and 
characterised from human masseter muscle 
biopsies obtained from healthy consented adult 
patients. Ethical approval had been obtained. 
Immunofluorescent markers to desmin and α-
sarcomeric actin confirmed myogenicity. 
Degradable iron-phosphate glasses were produced 
in disk and fibre form. The disks were coated with 
collagen and the fibres were aligned and coated 
with a thin layer of collagen or encased within a 
collagen gel. Cells were seeded on these scaffold 
combinations and a collagen gel was used as a 
control. Cell attachment, survival, alignment, 
differentiation and maturation over time were 
assessed using the CyQUANT assay, light and 
modulation contrast microscopy, 
immunofluorescence and RT-PCR.  
RESULTS:  
Disk Biocompatibility: There was good cell 
attachment and survival on collagen-coated disks. 
myoD and myogenin gene expression increased 
over the 14-day experimental period. Furthermore, 
there was an increase in the embryonic and 
neonatal myosin heavy chain gene expression by 
day 14 and variable expression of all other myosin 
heavy chains. 
Biomimetic Scaffold Response: Interestingly, cell 
orientation was unidirectional on the glass fibre 
and glass fibre-collagen scaffolds analogous to 
native skeletal muscle; this was in contrast to the 
collagen gel controls where the cell direction was 
random. The gene expression of myoD and 
myogenin was highest on the glass fibre scaffolds 
initially, however by day 21, the other scaffolds 
had greater expression (p<0.05). This was also the 
finding for all myosin heavy chains gene 
expression (p<0.05).  
 
FIGURE ONE: Expression of myogenin 
transcripts by skeletal jaw muscle constructs 
(determined by quantitative PCR). After 21 days in 
culture, the glass fibre-collagen composites show 
comparative performance to collagen gels alone. 
Both are superior to glass fibres alone. 
DISCUSSION & CONCLUSIONS: There was 
good cell biocompatibility with degradable iron-
phosphate glass disks. The creation of a 
biomimetic scaffold enabled orientation of the cells 
into the same direction to produce architecture 
similar to native skeletal muscle. Although the 
control collagen gels demonstrated evidence of 
muscle cell differentiation and maturation, as did 
the glass fibre scaffolds, these scaffolds may not be 
ideal for implantation: in particular, the collagen 
gels contracted uncontrollably. The glass fibre-
collagen gel scaffolds provided a much more 
manipulable system and have the potential to 
provide a suitable hard-soft tissue interface. 
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